CSIMarket


Johnson and Johnson  (JNJ)
Other Ticker:  
 

Johnson And Johnson's Long Term Debt to Equity

JNJ's quarterly Long Term Debt to Equity and Long Term Debt, Equity growth




JNJ Long Term Debt to Equity (Oct 03 2021)
III. Quarter
(Jul 04 2021)
II. Quarter
(Apr 04 2021)
I. Quarter
(Jan 03 2021)
IV. Quarter
(Sep 27 2020)
III. Quarter
Y / Y Equity Change 8.99 % 10.48 % 7.41 % 6.4 % 10.76 %
Y / Y Long Term Debt Change -7.8 % 20.94 % 19.18 % 23.18 % 21.4 %
Long Term Debt to Equity MRQ 0.43 0.44 0.46 0.52 0.51
Overall Ranking # # # # #
Seq. Equity Change 0.99 % 5.69 % 4.04 % -1.85 % 2.37 %
Seq. Long Term Debt Change -0.59 % 0.16 % -7.27 % -0.14 % 30.4 %



Long Term Debt to Equity third quarter 2021 Comment
Due to long-term debt repayement of -0.59% Johnson And Johnson improved Long Term Debt to Equity in third quarter 2021 to 0.43, above company's average Long Term Debt to Equity.

Within Major Pharmaceutical Preparations industry in the third quarter 2021, 65 other companies have achieved lower Long Term Debt to Equity than Johnson And Johnson. While total ranking remained unchanged compare to previous quarter at no. .

Explain Long Term Debt to Equity Ratio?
Learn more about JNJ
Long Term Debt to Equity Ratio JNJ on the trailing twelve month basis
Long Term Debt to Equity third quarter 2021 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 66
Healthcare Sector # 221
Overall Market # 1391


Long Term Debt to Equity Statistics
High Average Low
0.52 0.23 0.05
(Jan 03 2021)   (June 30. 2007)




Financial Statements
Johnson And Johnson's Equity $ 70,272 Millions Visit JNJ's Balance sheet
Johnson And Johnson's Long Term Debt $ 30,130 Millions Visit JNJ's Balance sheet
Source of JNJ's Sales Visit JNJ's Sales by Geography




Companies with similar Long Term Debt to Equity in the quarter endingOct 03 2021, within Major Pharmaceutical Preparations Industry Long Term Debt to EquityOct 03 2021 MRQ Long Term DebtOct 03 2021 MRQ Equity
Jaguar Health inc   1.16 $ 24.926  Millions$ 21.552  Millions
Axsome Therapeutics Inc   1.15 $ 49.174  Millions$ 42.718  Millions
Insmed Inc  1.10 $ 557.604  Millions$ 504.842  Millions
Prestige Consumer Healthcare Inc   1.09 $ 1,592.981  Millions$ 1,461.647  Millions
Bristol Myers Squibb Co  1.06 $ 39,677.000  Millions$ 37,284.000  Millions
Athenex Inc   1.05 $ 143.107  Millions$ 135.879  Millions
Catalent Inc   1.05 $ 4,225.000  Millions$ 4,021.000  Millions
Evoke Pharma Inc  1.05 $ 5.000  Millions$ 4.773  Millions
Amicus Therapeutics inc   1.03 $ 388.719  Millions$ 376.629  Millions
Viatris Inc   0.94 $ 19,854.300  Millions$ 21,141.300  Millions
Trevi Therapeutics inc   0.90 $ 10.245  Millions$ 11.380  Millions
Collegium Pharmaceutical inc   0.85 $ 213.570  Millions$ 251.094  Millions
Elanco Animal Health Inc  0.82 $ 6,273.000  Millions$ 7,682.000  Millions
Avalo Therapeutics Inc   0.81 $ 32.483  Millions$ 40.309  Millions
Innoviva Inc   0.80 $ 392.295  Millions$ 491.805  Millions
Scynexis inc   0.76 $ 28.579  Millions$ 37.614  Millions
Travere Therapeutics Inc   0.73 $ 223.696  Millions$ 307.370  Millions
Akebia Therapeutics Inc   0.71 $ 97.230  Millions$ 137.150  Millions
Zogenix Inc   0.69 $ 155.871  Millions$ 224.299  Millions
Assertio Holdings inc   0.69 $ 66.410  Millions$ 96.860  Millions
Rezolute Inc   0.65 $ 14.071  Millions$ 21.559  Millions
Aveo Pharmaceuticals Inc   0.64 $ 33.026  Millions$ 51.234  Millions
Merck and Co Inc   0.64 $ 22,907.000  Millions$ 35,863.000  Millions
Ocular Therapeutix Inc   0.58 $ 50.822  Millions$ 87.340  Millions
Horizon Therapeutics Public Limited Company  0.57 $ 2,557.864  Millions$ 4,450.214  Millions
Ironwood Pharmaceuticals inc   0.57 $ 333.212  Millions$ 579.941  Millions
Alnylam Pharmaceuticals Inc   0.57 $ 433.799  Millions$ 755.893  Millions
Perrigo Company Plc  0.56 $ 2,920.900  Millions$ 5,182.400  Millions
Marinus Pharmaceuticals Inc   0.52 $ 40.579  Millions$ 78.494  Millions
Abbott Laboratories  0.50 $ 17,446.000  Millions$ 34,638.000  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GSHN's Profile

Stock Price

GSHN's Financials

Business Description

Fundamentals

Charts & Quotes

GSHN's News

Suppliers

GSHN's Competitors

Customers & Markets

Economic Indicators

GSHN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071